Hamid is a clinical neuroscientist investigating Alzheimer’s disease diagnosis and treatment. He leads the WA Memory Study, a longitudinal study into the neuropsychological and biological markers dementia due to Alzheimer’s disease.
Dr Sohrabi completed his PhD in Psychiatry and Clinical Neurosciences at the University of Western Australia (UWA) in 2010. He has authored/co-authored more than 30 papers (23 in the last 5 year) in peer-reviewed journals including Lancet Neurology, Molecular Psychiatry, Neuroscience & Biobehavioral Reviews, Alzheimer’s and Dementia, Neurobiology of Aging, Journal of Alzheimer’s Disease, Translational Psychiatry and so on. Dr Sohrabi is a regular reviewer for different scientific journals as well as being on editorial boards of two journals. He has presented his data in national and international conferences and was awarded a young researcher’s travel fellowship by the American Alzheimer's Association to present at their International Conference (AAIC-2011) in Paris, France. He has also received the Professional Development Award (ASPIRE Professional Award) from Perth Convention Bureau, (Western Australia), May 2013. More recently, he was awarded an Early Career Excellence Award from the Edith Cowan University; ECU, in September 2014. Dr Sohrabi is the winner of the Cecilia Margaret Hudson Dementia Research Award from the Alzheimer’s Australia (2015). Dr Sohrabi’s work on depressive Endophenotype and future risk of AD as well as his work on olfactory and visual senses and their applications in diagnosing and predicting future pathological cognitive decline has received media attention, both nationally and internationally. Dr Sohrabi has recently joined the Department of Biomedical Sciences of Macquarie University on a part time basis, as the Associate Professor in Clinical Neurosciences.
Please leave a comment about your rating so we can better understand how we might improve the page.